| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.43 | 0.02 |